Fresenius Medical Care (ETR:FME) Stock Passes Above Two Hundred Day Moving Average – Should You Sell?

by · The Markets Daily

Fresenius Medical Care AG (ETR:FME – Get Free Report)’s stock price crossed above its 200-day moving average during trading on Thursday . The stock has a 200-day moving average of €38.44 ($39.22) and traded as high as €44.15 ($45.05). Fresenius Medical Care shares last traded at €43.51 ($44.40), with a volume of 458,800 shares trading hands.

Fresenius Medical Care Trading Up 1.2 %

The company has a debt-to-equity ratio of 77.56, a quick ratio of 0.80 and a current ratio of 1.46. The firm has a market capitalization of $12.93 billion, a P/E ratio of 24.35, a PEG ratio of 0.42 and a beta of 0.86. The firm has a 50 day simple moving average of €42.76 and a two-hundred day simple moving average of €38.49.

About Fresenius Medical Care

(Get Free Report)

Fresenius Medical Care AG provides dialysis and related services for individuals with renal diseases in Germany, North America, and internationally. The company offers dialysis treatment and related laboratory and diagnostic services through a network of outpatient dialysis clinics; materials, training, and patient support services comprising clinical monitoring, follow-up assistance, and arranging for delivery of the supplies to the patient’s residence; and dialysis services under contract to hospitals in the United States for the hospitalized end-stage renal disease (ESRD) patients and for patients suffering from acute kidney failure.

Further Reading